Binimetinib versus dacarbazine in patients with advanced NRAS -mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial
Dummer, Reinhard, Prof, Schadendorf, Dirk, Prof, Ascierto, Paolo A, MD, Arance, Ana, MD, Dutriaux, Caroline, MD, Di Giacomo, Anna Maria, MD, Rutkowski, Piotr, Prof, Del Vecchio, Michele, MD, Gutzmer, Ralf, Prof, Mandala, Mario, MD, Thomas, Luc, Prof, Demidov, Lev, Prof, Garbe, Claus, Prof, Hogg, David, MD, Liszkay, Gabriella, Prof, Queirolo, Paola, MD, Wasserman, Ernesto, MD, Ford, James, MS, Weill, Marine, MSc, Sirulnik, L Andres, MD, Jehl, Valentine, MSc, Bozón, Viviana, MD, Long, Georgina V, Prof, Flaherty, Keith, MD
Published in The lancet oncology (01.04.2017)
Published in The lancet oncology (01.04.2017)
Get full text
Journal Article
Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma
Bumma, Naresh, Richter, Joshua, Jagannath, Sundar, Lee, Hans C, Hoffman, James E, Suvannasankha, Attaya, Zonder, Jeffrey A, Shah, Mansi R, Lentzsch, Suzanne, Baz, Rachid, Maly, Joseph J, Namburi, Swathi, Pianko, Matthew J, Ye, Jing Christine, Wu, Ka Lung, Silbermann, Rebecca, Min, Chang-Ki, Vekemans, Marie-Christiane, Munder, Markus, Byun, Ja Min, Martínez-Lopez, Joaquín, Cassady, Kaniel, DeVeaux, Michelle, Chokshi, Dhruti, Boyapati, Anita, Hazra, Anasuya, Yancopoulos, George D, Sirulnik, L Andres, Rodriguez Lorenc, Karen, Kroog, Glenn S, Houvras, Yariv, Dhodapkar, Madhav V
Published in Journal of clinical oncology (01.08.2024)
Published in Journal of clinical oncology (01.08.2024)
Get full text
Journal Article
A phase II study of the EGFR inhibitor gefitinib in patients with acute myeloid leukemia
DeAngelo, Daniel J, Neuberg, Donna, Amrein, Philip C, Berchuck, Jacob E, Wadleigh, Martha, Sirulnik, L. Andres, Galinsky, Ilene, Golub, Todd, Stegmaier, Kimberly, Stone, Richard M
Published in Leukemia research (01.04.2014)
Published in Leukemia research (01.04.2014)
Get full text
Journal Article
NRG1 fusion-driven cancers: A systematic literature review and meta-analysis
Stalbovskaya, Viktoriya, Wasserman, Ernesto, Fryzek, Jon, Bylsma, Lauren C, Sirulnik, L. Andres
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
First-in-human phase 1/2 study of MCLA-128, a full length IgG1 bispecific antibody targeting HER2 and HER3: Final phase 1 data and preliminary activity in HER2+ metastatic breast cancer (MBC)
Alsina, Maria, Boni, Valentina, Schellens, Jan H.M., Moreno, Victor, Bol, Kees, Westendorp, Martine, Sirulnik, L. Andres, Tabernero, Josep, Calvo, Emiliano
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
A Phase 2 Study of Odronextamab (REGN1979), a CD20 x CD3 Bispecific Antibody, in Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
Kim, Tae Min, Alonso, Arancha, Prince, Miles, Taszner, Michal, Cho, Seok-Goo, Stevens, Don A., Poon, Michelle, Lim, Francesca, Le Gouill, Steven, Carpio, Cecilia, Keating, Mary-Margaret, Adriaens, Lieve, Ufkin, Melanie, Sabir, Ayesha, Li, Jingjin, Jankovic, Vladimir, Zhu, Min, Brouwer-Visser, Jurriaan, Leng, Siyang, Sirulnik, L. Andres, Chaudhry, Aafia, Ambati, Srikanth R., Won Seog, Kim
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
REGN5458, a BCMA x CD3 Bispecific Monoclonal Antibody, Induces Deep and Durable Responses in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
Madduri, Deepu, Rosko, Ashley, Brayer, Jason, Zonder, Jeffrey, Bensinger, William I., Li, Jingjin, Xu, Linzhi, Adriaens, Lieve, Chokshi, Dhruti, Zhang, Weijiang, Boyapati, Anita, Sharma, Manish, Seebach, Frank, Sirulnik, L. Andres, Weinreich, David M., Yancopoulos, George D., Dhodapkar, Madhav V., Lentzsch, Suzanne, Cooper, Dennis, Jagannath, Sundar
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Abstract PR02: Clinical proof of concept for MCLA-128, a bispecific HER2/3 antibody therapy, in NRG1 fusion-positive cancers
Schram, Alison M, O’Reilly, Eileen M, Somwar, Romel, Benayed, Ryma, Shameem, Sara, Chauhan, Thrusha, Torrisi, Jean, Ford, Jim, Maussang, David, Wasserman, Ernesto, Ladanyi, Marc, Hyman, David M, Sirulnik, L. Andres, Drilon, Alexander
Published in Molecular cancer therapeutics (01.12.2019)
Published in Molecular cancer therapeutics (01.12.2019)
Get full text
Journal Article
Clinical activity of MCLA-128 (zenocutuzumab) in combination with endocrine therapy (ET) in ER+/HER2-low, non-amplified metastatic breast cancer (MBC) patients (pts) with ET-resistant disease who had progressed on a CDK4/6 inhibitor (CDK4/6i)
Pistilli, Barbara, Wildiers, Hans, Hamilton, Erika Paige, Ferreira, Ana Alexandra, Dalenc, Florence, Vidal, Maria, Gavilá, Joaquín, Goncalves, Anthony, Murias, Carmen, Mouret-Reynier, Marie-Ange, Canon, Jean-Luc Re, Bazan, Fernando, Ladoire, Sylvain, Sirulnik, L. Andres, Bekradda, Mohamed, Bol, Kees, Stalbovskaya, Viktoriya, Murat, Anastasia, Ford, Jim, Bidard, Francois Clement
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Results of NEMO: A phase III trial of binimetinib (BINI) vs dacarbazine (DTIC) in NRAS -mutant cutaneous melanoma
Dummer, Reinhard, Schadendorf, Dirk, Ascierto, Paolo Antonio, Arance Fernández, Ana Maria, Dutriaux, Caroline, Maio, Michele, Rutkowski, Piotr, Del Vecchio, Michele, Gutzmer, Ralf, Mandalà, Mario, Thomas, Luc, Wasserman, Ernesto, Ford, James, Weill, Marine, Sirulnik, L. Andres, Jehl, Valentine, Bozon, Viviana, Long, Georgina V., Flaherty, Keith
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Identification of pSTAT5 gene signature in hematologic malignancy
Sonkin, Dmitriy, Regnier, Catherine, Rong, Xianhui, Fanton, Christie, Palmer, Michael, Holash, Jocelyn, Squires, Matthew, Sirulnik, L. Andres, Radimerski, Thomas, Schlegel, Robert, Morrissey, Michael, Cao, Z, Alexander
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Association of cytokine levels and reductions in spleen size in COMFORT-II, a phase III study comparing ruxolitinib to best available therapy (BAT)
Harrison, Claire N, Kiladjian, Jean-Jacques, Gisslinger, Heinz, Passamonti, Francesco, Sirulnik, L. Andres, Wang, Ling, Squires, Matthew, Knoops, Laurent, Barosi, Giovanni, Barbui, Tiziano, Cervantes, Francisco
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Health-related quality of life (HRQoL) and symptom burden in patients (Pts) with myelofibrosis (MF) in the COMFORT-II study
Kiladjian, Jean-Jacques, Gisslinger, Heinz, Passamonti, Francesco, Niederwieser, Dietger, Mendelson, Estella, Sirulnik, L. Andres, Copley-Merriman, Kati, Zhou, Xiaolei, Levy, Richard S., Knoops, Laurent, Cervantes, Francisco, Barbui, Tiziano, Barosi, Giovanni, Vannucchi, Alessandro M., Harrison, Claire N
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
A phase Ib, open-label, dose-finding study of ruxolitinib in patients (pts) with primary myelofibrosis (PMF), post-polycythemia vera-myelofibrosis (PPV-MF), or post-essential thrombocythemia-myelofibrosis (PET-MF) and baseline platelets (PLTs) 50 to <100 x 10 9 /l
Gisslinger, Heinz, McMullin, Mary Frances, Jaekel, Nadja, Miller, Carole Brennan, Verstovsek, Srdan, Harrison, Claire N, Barosi, Giovanni, Kiladjian, Jean-Jacques, Al-Ali, Haifa-Kathrin, Weber, Denis, Hu, Jing, Sirulnik, L. Andres, Vannucchi, Alessandro M.
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Reductions in JAK2 V617F allele burden with ruxolitinib treatment in COMFORT-II, a phase III study comparing the safety and efficacy of ruxolitinib to best available therapy (BAT)
Vannucchi, Alessandro M., Kiladjian, Jean-Jacques, Gisslinger, Heinz, Passamonti, Francesco, Al-Ali, Haifa Kathrin, Sirulnik, L. Andres, Stalbovskaya, Viktoriya, Squires, Matthew, Hunter, Deborah S., Burn, Timothy, Knoops, Laurent, Cervantes, Francisco, Barbui, Tiziano, Barosi, Giovanni, Harrison, Claire N
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
A Multicenter Phase II Study Using a Dose Intensified Pediatric Regimen in Adults with Untreated Acute Lymphoblastic Leukemia
DeAngelo, Daniel J., Dahlberg, Suzanne, Silverman, Lewis B., Couban, Stephen, Amrein, Philip C., Seftel, Matthew D., Turner, A. Robert, Leber, Brian, Howsan-Jan, Kang, Wadleigh, Martha, Sirulnik, L. Andres, Supko, Jeffrey, Galinsky, Ilene, Sallan, Stephen E., Stone, Richard M.
Published in Blood (16.11.2007)
Published in Blood (16.11.2007)
Get full text
Journal Article
A Multicenter Phase II Study Using a Dose Intensified Pediatric Regimen in Adults with Untreated Acute Lymphoblastic Leukemia
DeAngelo, Daniel J., Silverman, Lewis B., Couban, Stephen, Dahlberg, Suzanne, Amrein, Philip C., Seftel, Matthew D., Turner, A. Robert, Wadleigh, Martha, Sirulnik, L. Andres, Galinsky, Ilene, Sallan, Stephen E., Stone, Richard M.
Published in Blood (16.11.2006)
Published in Blood (16.11.2006)
Get full text
Journal Article
A Phase I-II Pilot Study of Divalproex Sodium Alone and in Combination with All-Trans-Retinoic Acid (ATRA) in Relapsed or Refractory Acute Myeloid Leukemia
Gabrilove, Janice L., McConnell, Melanie-Jane, Berkofsky-Fessler, Windy, Sirulnik, Andres L., Sharma, Sanjay, Silverman, Lewis R., Isola, Luis, Mandeli, John, Licht, Jonathan
Published in Blood (16.11.2005)
Published in Blood (16.11.2005)
Get full text
Journal Article